|
GSK rejects conclusions of Senate Committee on Finance Staff Report on Avandia
|
22 February 2010 |
|
GSK rejects conclusions reported in The New York Times story on Avandia
|
21 February 2010 |
|
GlaxoSmithKline and XenoPort receive FDA Complete Response letter for Horizantâ¢
|
19 February 2010 |
|
GSK launches new specialist unit to research and develop medicines for rare diseases
|
08 February 2010 |
|
GSK publishes speaking, consulting fees paid to US healthcare professionals
|
17 December 2009 |
|
GSK and Intercell form strategic alliance to develop and commercialise innovative vaccines
|
14 December 2009 |
|
GSK's Arepanrix⢠H1N1 pandemic vaccine prequalified by the World Health Organization
|
03 December 2009 |
|
GSK and Nabi announce agreement for NicVAX®, a vaccine for nicotine addiction
|
19 November 2009 |
|
FDA approves GSK's pandemic H1N1 vaccine
|
12 November 2009 |
|
WHO Grants Prequalification for Global Use to GSK's 10-Valent Synflorix⢠Vaccine
|
09 November 2009 |